Primary record
2-Amino-N-((1S,2R,3R,4S,5S,6R)-4-amino-3-(((2R,3R,6S)-3-amino-6-((S)-1-aminoethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylacetamide
- 库存
- 2,786 克
- 纯度
- 98.5 %
- CAS
- 55779-06-1
化合物标识与属性
- CAS
- 55779-06-1
- PubChem CID
- 5284517
- SMILES
- C[C@@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H]([C@@H]([C@H]([C@H]2O)N(C)C(=O)CN)OC)O)N)N)N
- Canonical SMILES
- CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN
名称与同义词
- Astromicin
- Fortimicin A
- Astromicina
- Astromicine
- Fortimicin
- Astromicinum
- astromycin
- Astromicin A
- Antibiotic KW-1070
- ASTM
- Astromicin [INN]
- astromicin sulfate
- Astromicin (INN)
- Astromicin [USAN]
- Astromicine [INN-French]
- Astromicinum [INN-Latin]
- Antibiotic KW 1070
- Astromicina [INN-Spanish]
- Abbott 44747
- AC1NR4LV
- RefChem:115364
- 7JHD84H15J
- UNII-7JHD84H15J
- 55779-06-1
- DTXSID2022624
- KW-1070
- XK-70-1
- FORTIMICIN A [MI]
- DTXCID602624
- ASTROMICIN [WHO-DD]
- KW 1070
- XK 70-1
- CHEBI:37923
- SCHEMBL158389
- orb1698305
- CHEMBL3084803
- C17H35N5O6
- ZINC4654843
- Tox21_113387
- BBF-01847
- AKOS040750610
- C17-H35-N5-O6
- CID5284517
- NCGC00185750-01
- J34.182G
- CAS-55779-06-1
- HY-123162
- CS-0081586
- FT-0630687
- NS00011544
- C17708
- D07470
- 4-Amino-1-((aminoacetyl)methylamino)-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol
- Q4811598
- 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-[(1S)-1-aminoethyl]oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide
- 4-amino-1-(2-amino-N-methylacetamido)-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol
- N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-({(2R,3R,6S)-3-amino-6-[(1S)-1-aminoethyl]tetrahydro-2H-pyran-2-yl}oxy)-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylglycinamide
- (1R,2S,3S,4R,5S,6R)-2-amino-5-[glycyl(methyl)amino]-3,6-dihydroxy-4-(methyloxy)cyclohexyl 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside
- (1R,2S,3S,4R,5S,6R)-2-Amino-5-[glycyl(methyl)amino]-3,6-dihydroxy-4-methoxycyclohexyl 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside
- 2-Amino-N-((1S,2R,3R,4S,5S,6R)-4-amino-3-(((2R,3R,6S)-3-amino-6-((S)-1-aminoethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylacetamide
- 2-amino-N-((1S,2R,3R,4S,5S,6R)-4-amino-3-((2R,3R,6S)-3-amino-6-((1S)-1-aminoethyl)oxan-2-yl)oxy-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylacetamide
- 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-{[(2R,3R,6S)-3-amino-6-[(1S)-1-aminoethyl]oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide
- 4-Amino-1-[(aminoacetyl)methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol
- 4-Amino-1-[(aminoacetyl)methylamino]-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1,4-dideoxy-L-chiro-inositol
- 4-Amino-1-[methyl(aminoacetyl)amino]-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1,4-dideoxy-L-chiro-inositol
- L-chiro-Inositol, 4-amino-1-((aminoacetyl)methylamino)-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-
- N-((1S,2R,3R,4S,5S,6R)-4-amino-3-(((2R,3R,6S)-3-amino-6-((1S)-1-aminoethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylglycinamide